Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Kalamazoo, MI
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Troy, MI
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Troy, MI
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Bozeman, MT
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Bozeman, MT
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Bellevue, NE
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Bellevue, NE
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Omaha, NE
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Berlin, NJ
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Brooklyn, NY
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Garden City, NY
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Garden City, NY
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Charlotte, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Fayetteville, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Fayetteville, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Hickory, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Hickory, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Lexington, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Lexington, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Mooresville, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Mooresville, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Morganton, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Morganton, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Winston-Salem, NC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Canton, OH
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Centerville, OH
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Centerville, OH
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Cincinnati, OH
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Dayton, OH
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Oklahoma City, OK
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Tulsa, OK
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Harleysville, PA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Harleysville, PA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Scottdale, PA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Scottdale, PA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Smithfield, PA
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Smithfield, PA
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Johnston, RI
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Johnston, RI
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Charleston, SC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
West Columbia, SC
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
West Columbia, SC
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Rapid City, SD
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Rapid City, SD
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Franklin, TN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Franklin, TN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Jackson, TN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Jackson, TN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Nashville, TN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
New Tazewell, TN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
New Tazewell, TN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Smyrna, TN
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Smyrna, TN
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Addison, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Addison, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Austin, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Baytown, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Baytown, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Carrollton, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Carrollton, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Channelview, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Channelview, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Corpus Christi, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Dallas, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
DeSoto, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Houston, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
McAllen, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
McAllen, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Pharr, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Pharr, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Plano, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Plano, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
San Angelo, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
San Angelo, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
San Antonio, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Sugar Land, TX
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Draper, UT
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Draper, UT
Click here to add this to my saved trials
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated:  3/30/2017
Shionogi Research Site
mi
from
Salt Lake City, UT
A Study of S-033188 Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared With Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients With Influenza
Status: Enrolling
Updated: 3/30/2017
Shionogi Research Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials